Indian Journal of Pharmacology Home 

RESEARCH ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2011  |  Volume : 43  |  Issue : 5  |  Page : 532--535

Evaluation of Chinese medicine Qian-Yu for chronic bacterial prostatitis in rats

Jinhu Wu1, Qianying Yuan2, Daohua Zhang3, Xiaoyan Zhang4, Lijun Zhao4, Xiaohua Zhang5, Jinlan Ruan2 
1 Department of Pharmacology, Tongji Medical College of Huazhong University of Science and Technology, Wuhan; Department of Pharmacy, The Third Renmin Hospital, Wuhan, China
2 Department of Pharmacology, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
3 Department of Radiology, Xiehe Hospital, Tongji Medical College of Huanzhong University of Science and Technology, Wuhan, China
4 Department of Pharmacology, Affiliated Renmin Hospital of Yunyang Medical College, Shiyan, China
5 Hubei Bureau of Quality and Technical Supervision, Wuhan, China

Correspondence Address:
Jinlan Ruan
Department of Pharmacology, Tongji Medical College of Huazhong University of Science and Technology, Wuhan
China

Objectives : Qian-Yu (QY), a Chinese medicine formula, has anti-inflammatory and broad spectrum anti-bacterial activity. This study is undertaken to evaluate the anti-inflammatory effects of Qian-Yu (QY) in chronic bacterial prostatitis (CBP). Materials and Methods : The potential of QY in the treatment of CBP was evaluated using a CBP animal model by examining the anti-inflammatory activity. Its consequences were analyzed by immunological and histopathological methods. Experimental chronic bacterial prostatitis was induced by instillation of bacterial suspension of Escherichia coli 7.5 ΄ 10 5 CFU/ml into the prostatic urethra. Animals were followed up for four weeks and then treated with either 7 mg/kg QY or 7 mg/kg positive control agent-Qianlietai (QLT) or 1 ml of phosphate-buffered saline (PBS) for the controls. Ten rats in each group were sacrificed at the end of four weeks. The inhibition of inflammation and its consequences were analyzed histologically. Prostatic IL-8, SIgA and zinc concentrations were measured by ELISA, RIA and ICP-AES, respectively. The data was expressed as mean ± S.D. Least-significant difference (LSD) of one-way ANOVA (SPSS 12.0) was used to determine the differences of scores. Results : The histopathology showed resolving prostatitis in QY-and QLT-treated groups and the immunology showed reduction of IL-8 and increment of SIgA contents in prostatic tissues as compared to the control groups. The prostatic zinc levels were higher in the QY-and QLT-treated groups than those in the controls. These results suggested that QY is effective in CBP treatment.


How to cite this article:
Wu J, Yuan Q, Zhang D, Zhang X, Zhao L, Zhang X, Ruan J. Evaluation of Chinese medicine Qian-Yu for chronic bacterial prostatitis in rats.Indian J Pharmacol 2011;43:532-535


How to cite this URL:
Wu J, Yuan Q, Zhang D, Zhang X, Zhao L, Zhang X, Ruan J. Evaluation of Chinese medicine Qian-Yu for chronic bacterial prostatitis in rats. Indian J Pharmacol [serial online] 2011 [cited 2021 Sep 17 ];43:532-535
Available from: https://www.ijp-online.com/article.asp?issn=0253-7613;year=2011;volume=43;issue=5;spage=532;epage=535;aulast=Wu;type=0